Hainan Haiyao Co Ltd. Stock Analysis 000566.SZ

Hainan Haiyao Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. The company is headquartered in Haikou, Hainan and currently employs 1,738 full-time employees. The firm's main business covers intermediates, Active Pharmaceutical Ingredients (APIs), chemical preparations, modern Chinese medicine and medical services. The firm's products include antibiotic series, gastrointestinal medicine series, anti-tumor drug series, APIs and intermediates series supporting preparations and others. The main products are Cefuroxime Sodium for Injection, Changweikang Series, Paclitaxel Injection, Cefuroxime Sodium, Desloratadine Oral Solution, Xiaochaihu Granules and others. The firm mainly operates its businesses in the domestic and overseas markets.